FamiCord AG (ETR:V3V)

Market Cap	71.47M
Revenue (ttm)	80.64M
Net Income (ttm)	2.58M
Shares Out	17.43M
EPS (ttm)	0.15
PE Ratio	28.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,340
Average Volume	2,569
Open	4.100
Previous Close	4.200
Day's Range	4.100 - 4.220
52-Week Range	3.700 - 5.250
Beta	0.67
RSI	51.22
Earnings Date	Apr 30, 2025

About FamiCord AG

FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the compa...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1997
• Employees: 745
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: V3V

Financial Performance

In 2023, FamiCord AG's revenue was 77.06 million, an increase of 11.78% compared to the previous year's 68.94 million. Losses were -1.87 million, -93.11% less than in 2022.